The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

Study Questions:

What are long-term effects of the two doses of dabigatran—110 and 150 mg twice daily—in patients completing the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial?